Medical Publications Planning

$3,495.00

Medical publications budgets are rising, but teams must still demonstrate value to support increased output. This report is the perfect benchmarking tool for medical publications managers seeking to track performance metrics that showcase their teams’ strategic value. Use findings to institute publications group structures that foster robust interteam communication, and implement regular training to foster compliant medical publications teams. Track metrics to showcase strategic value, and employ proactive transparency practices to benefit both the company and the public. Consider open access journals as an option for publishing low-impact trials.

Download Now! speak-to-an-expert

Report Details

Publication Date: June 2014
Pages: 285
Chapters: 5
Metrics: 500+
Charts/Graphics: 197

Top Reasons to Buy This Medical Publications Planning Report

Improve Transparency around Medical Publications:Transparency is of growing importance to both the pharmaceutical industry and scientific community.  New methods (open access journals, online portals, etc.) have emerged that help companies release data.  This report includes case studies illustrating shows how top-performing pharmaceutical companies use digital tools to achieve transparency while addressing patient confidentiality concerns.  The data also provide a detailed overview of the latest updates to publications guidelines and regulations around transparency.  Lastly, the report highlights companies’ perception of the impact of CIAs on publications processes.

Prove Medical Publications Team Value by Tracking Hard Metrics: Traditional performance metrics — such as manuscript/abstract volume, number of citations and acceptance rates — help paint a picture of the publications team’s activity levels.  But they don’t fully prove the team’s value to upper management.  This report includes performance metrics of both high- and low-output teams, as well as illustrates how life sciences companies communicate those metrics into value statements about the impact of medical publications.

Prepare Medical Writers for Global Compliance Challenges: Most medical affairs teams adhere to industry standards — such as the ICMJE — and incorporate company-specific regulations to build airtight standard operating procedures.  But those SOPs alone won’t always guarantee full compliance, especially when regulations around the world change frequently.  Cutting Edge Information’s study includes detailed metrics on the number of compliance training hours that medical publications employees undergo.  It also includes best practices for working with key opinion leaders on the impact of regulations, such as the Sunshine Act, on compensation for authoring medical publications.

You may also be interested in our medical affairs library as well as our individual medical affairs research reports.

Excerpt from Medical Publications Planning

In the medical publications landscape, there are multiple elements to transparency. Transparency exists both with respect to companies’ clinical trial data and to authors’ publications activities. Across the life sciences industry, companies continue to make data disclosure a priority. With global and industry initiatives in place, they have broadened their dedication to achieving clinical data transparency. These initiatives include AllTrials and the partnership between the European Federation of Pharmaceutical Industries (EFPIA) and Pharmaceutical Research and Manufacturers (PhRMA).

Additionally, online clinical trial registries enable companies to publish clinical trial findings online. In 2013, the European Medicines Agency (EMA) released a European online trial registry, similar to Clinicaltrials.gov in the US. The registry is aligned with Clinicaltrials.gov and known as the European Clinical Trials Database (EudraCT). In April 2014, this AllTrials equivalent established a formal foothold in Europe. Beginning as early as 2016, companies operating in the EU will need to publicly register their trials and record their results.

Table of Contents

14           Executive Summary

14           Clinical Data Transparency Facilitates Growing Need for Timely, Compliant Medical Publications

19           Study Methodology

20           Study Definitions

22           Medical Publications: Five Recommendations for Success

32           Developing Structure and Staffing Elements to Address Publication Needs

34           Exploring the Benefits of Centralized and Decentralized Publications Structures

47           Establishing the Number of Groups Necessary to Support Publications Activities

56           Expanding Internal and External Staffing Resources

87           Right-sizing Budgets and External Resources to Support Medical Publications

88           Matching Medical Publications Funding to Group Responsibilities and Activity Level

113         Leveraging Third-Party Vendors to Drive Publications Initiatives

145        Demonstrating Medical Publications Success Through Performance Measurement

151        Developing a Medical Publications Strategy: Establishing Timelines, Coordinating Activities and Targeting Key Journal Types

153        Publications Strategy Overview

173        Companies’ Publications Processes: Manuscript Development

193        Companies’ Publications Processes: Abstract Development

204        Choosing and Submitting to the Best-Fit Journal

225        Existing Challenges and Overall Perceptions of Current Publications Processes

233         Benefits and Challenges of Increasing Transparency Across Publications

236        Advantages to the Public and Industry Driving Increased Transparency

242        Adhere Strictly to Multiple Sets of Guidelines for Optimal Transparency

259         Medical Publications Team Profiles

CHARTS AND GRAPHICS

14           Executive Summary

14           Clinical Data Transparency Facilitates Growing Need for Timely, Compliant Medical Publications

22           Medical Publications: Five Recommendations for Success

23           Figure E.1: Preferred Publications Group Structures: All Teams

25           Figure E.2: Number of Hours Dedicated to Compliance Training for Publications Teams, by Team Type

26           Figure E.3: Percentage of Teams that Provide Compensation for Publications Compliance Training, by Team Type

27           Figure E.4: Performance Metrics Measured: All Medical Publications Teams

32           Developing Structure and Staffing Elements to Address Publications Needs

34           Exploring the Benefits of Centralized and Decentralized Publications Structures

35           Figure 1.1: Preferred Publications Group Structures: All Teams

35           Figure 1.2: Preferred Publications Group Structures: Companywide Teams

36           Figure 1.3: Preferred Publications Group Structures: Corporate-Level Business Unit Teams

36           Figure 1.4: Preferred Publications Group Structures: Country-Level Teams

37           Figure 1.5: Medical Publications Group Structure: Company C (Small Company)

39           Figure 1.6: Preferred Publications Group Structures: All High-Output Teams

40           Figure 1.7: Preferred Publications Group Structures: All Low-Output Teams

42           Figure 1.8: Structure of Companies’ Dedicated Publications Group, by Team Type

43           Figure 1.9: Function Overseeing Publications at Companies Without Dedicated Publications Teams, by Team Type

44           Figure 1.10: Functions Involved in Publications Processes: All Teams

45           Figure 1.11: Functions Involved in Publications Processes: Companywide Teams

45           Figure 1.12: Functions Involved in Publications Processes: Corporate-Level Business Unit Teams

46           Figure 1.13: Functions Involved in Publications Processes: Country-Level Teams

47           Establishing the Number of Groups Necessary to Support Publications Activities

48           Figure 1.14: Number of Publications Groups, by Team Type

48           Figure 1.15: Specific Number of Publications Groups, by Team Type

50           Figure 1.16: Specific Number of Publications Groups, by Company Size

51           Figure 1.17: Number of Publications Groups, by Output Level

53           Figure 1.18: Percentage of Teams with Dedicated Publications Groups

54           Figure 1.19: Percentage of Teams with Dedicated Publications Groups: All High-Output Teams

55           Figure 1.20: Percentage of Teams with Dedicated Publications Groups: All Low-Output Teams

56           Expanding Internal and External Staffing Resources

57           Figure 1.21: Level of Executive in Charge of Publications, by Team Type

57           Figure 1.22: Level of Executive in Charge of Publications at Companywide Teams, by Company Size

58           Figure 1.23: Level of Executive in Charge of Publications at Corporate-Level Business Unit Teams, by Company Size

59           Figure 1.24: Level of Executive in Charge of Publications at Country-Level Teams, by Company Size

61           Figure 1.25: In-House Publications Team Staffing, by Company Size: Companywide Teams at Top 20 and Top 50 Companies

61           Figure 1.26: In-House Publications Team Staffing, by Company Size: Companywide Teams at Small Companies

62           Figure 1.27: In-House Publications Team Staffing, by Company Size: Companywide Teams of More Small and Device Companies

62           Figure 1.28: Average In-House Companywide Publications Team Staffing, by Company Size

63           Figure 1.29: Outsourced Publication Staffing, by Company Size: Companywide Teams

63           Figure 1.30: Average Outsourced Companywide Publications Team Staffing, by Company Size

64           Figure 1.31: In-House Publications Team Staffing, by Company Size: Corporate-Level Business Unit Teams at Top 20 and Top 50 Companies

65           Figure 1.32: In-House Publications Team Staffing, by Company Size: Corporate-Level Business Unit Teams at Small and Device Companies

65           Figure 1.33: Average In-House Corporate-Level Business Unit Publications Team Staffing, by                           Company Size

66           Figure 1.34: Outsourced Publications Team Staffing, by Company Size: Corporate-Level Business Unit Teams

66           Figure 1.35: Average Outsourced Corporate-Level Business Unit Publications Team Staffing, by                      Company Size

67           Figure 1.36: In-House Publications Team Staffing, by Company Size: All Country-Level Teams

68           Figure 1.37: Average In-House Country-Level Publications Team Staffing, by Company Size

68           Figure 1.38: Outsourced Publications Team Staffing, by Company Size: All Country-Level Teams

69           Figure 1.39: Number of Hours Dedicated to Compliance Training for Publications Teams, by Team Type

71           Figure 1.40: Percentage of Teams that Provide Compensation for Publications Compliance Training, by Team Type

73           Figure 1.41: Companies’ In-House Publications Team Staffing Changes from 2011 to 2013

74           Figure 1.42: Companies’ Outsourced Publications Team Staffing Changes from 2011 to 2013

75           Figure 1.43: Change in Companywide Publications Teams’ Staffing from 2011 to 2013: Top 20 and Top 50 Companies

75           Figure 1.44: Change in Companywide Publications Teams’ Staffing from 2011 to 2013: Small Companies

76           Figure 1.45: Change in Companywide Publications Teams’ Staffing from 2011 to 2013: More Small and Device Companies

76           Figure 1.46: Average Change in Companywide Publications Teams’ Staffing from 2011 to 2013, by Company Size

77           Figure 1.47: Change in Corporate-Level Business Unit Publications Teams’ Staffing from 2011 to 2013: Top 20 and Top 50 Companies

77           Figure 1.48: Change in Corporate-Level Business Unit Publications Teams’ Staffing from 2011 to 2013: Small and Device Companies

78           Figure 1.49: Average Change in Corporate-Level Business Unit Publications Teams’ Staffing from 2011 to 2013, by Company Size

78           Figure 1.50: Change in All Country-Level Publications Teams’ In-House Staffing from 2011 to 2013

79           Figure 1.51: Average Change in All Country-Level Publications Teams’ Staffing from 2011 to 2013, by Company Size

80           Figure 1.52: Companies’ Anticipated In-House Publications Team Staffing Changes from 2013 to 2015

81           Figure 1.53: Companies’ Anticipated Publications Team Outsourced Staffing Changes from 2013 to 2015

82           Figure 1.54: Anticipated Change in Companywide Publications Teams’ Staffing from 2013 to 2015: Top 20 and Top 50 Companies

82           Figure 1.55: Anticipated Change in Companywide Publications Teams’ Staffing from 2013 to 2015: Small Companies

83           Figure 1.56: Anticipated Change in Companywide Publications Teams’ Staffing from 2013 to 2015: More Small and Device Companies

83           Figure 1.57: Average Anticipated Change in Companywide Publications Teams’ Staffing from 2013 to 2015, by Company Size

84           Figure 1.58: Anticipated Change in Corporate-Level Business Unit Publications Teams’ Staffing from 2013 to 2015: Top 20 and Top 50 Companies

84           Figure 1.59: Anticipated Change in Corporate-Level Business Unit Publications Teams’ Staffing from 2013 to 2015: Small and Device Companies

85           Figure 1.60: Average Anticipated Change in Corporate-Level Business Unit Publications Teams’ Staffing from 2013 to 2015, by Company Size

85           Figure 1.61: Anticipated Change in All Country-Level Publications Teams’ Staffing from 2013 to 2015

86           Figure 1.62: Average Anticipated Change in All Country-Level Publications Teams’ Staffing from 2013 to 2015, by Company Size

87           Right-Sizing Budgets and External Resources to Support Medical Publications

88           Matching Medical Publications Funding to Group Responsibilities and Activity Level

89           Figure 2.1: Annual Medical Publications Team Budgets at Top 20 and Top 50 Companies: Companywide Publications Teams

90           Figure 2.2: Annual Medical Publications Team Budgets at Small and Device Companies: Companywide Publications Teams

91           Figure 2.3: Change in Team Budget from 2013 to 2014 at Top 20 and Top 50 Companies: Companywide Publications Teams

92           Figure 2.4: Change in Team Budget from 2013 to 2014 at Small and Device Companies: Companywide Publications Teams

94           Figure 2.5: Annual Medical Publications Budgets for High-Output Teams: Companywide Publications Teams

94           Figure 2.6: Annual Medical Publications Budgets for Low-Output Teams: Companywide Publications Teams

95           Figure 2.7: Annual Medical Publications Spending for High-Output Groups: Companywide Publications Teams

96           Figure 2.8: Annual Medical Publications Spending for Low-Output Groups: Companywide Publications Teams

97           Figure 2.9: Percentage of Budget Dedicated to Specific Activities for High-Output Teams:                                 Companywide Publications Teams

98           Figure 2.10: Percentage of Budget Dedicated to Specific Activities for Low-Output Teams:                               Companywide Publications Teams

99           Figure 2.11: Medical Publications Team Funding Process: Company E (Top 20 Company with a High Output Team)

101         Figure 2.12: Annual Medical Publications Team Budgets at Top 20 Companies: Corporate-Level Business Unit Publications Teams

102        Figure 2.13: Annual Medical Publications Team Budgets at Small Companies: Corporate-Level Business Unit Publications Teams

103        Figure 2.14: Change in Team Budget from 2013 to 2014 at Top 20 Companies: Corporate-Level Business Unit Publications Teams

104        Figure 2.15: Change in Team Budget from 2013 to 2014 at Small Companies: Corporate-Level Business Unit Publications Teams

106        Figure 2.16: Annual Medical Publications Budgets for High-Output Teams: Corporate-Level Business Unit Publications Teams

106         Figure 2.17: Annual Medical Publications Budgets for Low-Output Teams: Corporate-Level Business Unit Publications Teams

107        Figure 2.18: Annual Medical Publications Spending: Corporate-Level Business Unit Publications Teams

108         Figure 2.19: Percentage of Budget Dedicated to Specific Activities: Corporate-Level Business Unit Publications Teams

109        Figure 2.20: Annual Medical Publications Team Budgets: Country-Level Publications Teams

110        Figure 2.21: Change in Team Budget from 2013 to 2014: Country-Level Publications Teams

111        Figure 2.22: Annual Medical Publications Spending: Country-Level Publications Teams

112         Figure 2.23: Percentage of Budget Dedicated to Specific Activities: Country-Level Publications                       Teams

113        Leveraging Third-Party Vendors to Drive Publications Initiatives

121        Figure 2.24: Percentage of Workload Outsourced for Top 20 and Top 50 Companies: Companywide Publications Teams

121        Figure 2.25: Percentage of Workload Outsourced for Small and Device Companies: Companywide Publications Teams

123         Figure 2.26: Percentage of Companies Outsourcing Specific Activities: Companywide Publications Teams

124         Figure 2.27: Average Percentage of Workload Outsourced for Specific Activities: Companywide   Publications Teams

125        Figure 2.28: Percentage of Workload Outsourced for High-Output Teams: Companywide Teams

126        Figure 2.29: Percentage of Workload Outsourced for Low-Output Teams: Companywide Teams

127         Figure 2.30: Percentage of High-Output Companies Outsourcing Specific Activities: Companywide Publications Teams

128         Figure 2.31: Average Percentage of High-Output Team Workload Outsourced for Specific Activities: Companywide Publications Teams

129         Figure 2.32: Percentage of Low-Output Companies Outsourcing Specific Activities: Companywide Publications Teams

130         Figure 2.33: Average Percentage of Low-Output Team Workload Outsourced for Specific Activities: Companywide Publications Teams

131         Figure 2.34: Percentage of Workload Outsourced for Top 20 and Top 50 Companies: Corporate Level Business Unit Publications Teams

132         Figure 2.35: Percentage of Workload Outsourced for Small and Device Companies: Corporate Level Business Unit Publications Teams

134         Figure 2.36: Percentage of Companies Outsourcing Specific Activities: Corporate-Level Business Unit Publications Teams

135         Figure 2.37: Average Percentage of Workload Outsourced for Specific Activities: Corporate-Level Business Unit Publications Teams

136        Figure 2.38: Percentage of Workload Outsourced for High-Output Teams: Corporate-Level Business Unit Teams

137         Figure 2.39: Percentage of Workload Outsourced for Low-Output Teams: Corporate-Level Business Unit Teams

138         Figure 2.40: Percentage of High-Output Companies Outsourcing Specific Activities: Corporate-Level Business Unit Publications Teams

139         Figure 2.41: Average Percentage of High-Output Team Workload Outsourced for Specific Activities: Corporate-Level Business Unit Publications Teams

140         Figure 2.42: Percentage of Low-Output Companies Outsourcing Specific Activities: Corporate-Level Business Unit Publications Teams

141         Figure 2.43: Average Percentage of Low-Output Team Workload Outsourced for Specific Activities: Corporate-Level Business Unit Publications Teams

142        Figure 2.44 Percentage of Workload Outsourced: Country-Level Publications Teams

143         Figure 2.45: Percentage of Companies Outsourcing Specific Activities: Country-Level Publications Teams

144         Figure 2.46: Average Percentage of Workload Outsourced for Specific Activities: Country-Level                    Publications Teams

145        Demonstrating Medical Publications Success Through Performance Measurement

148        Figure 2.47: Performance Metrics Measured: All Medical Publications Teams

149        Figure 2.48: Performance Metrics Measured: Companywide Publications Teams

150        Figure 2.49: Performance Metrics Measured: Corporate-Level Business Unit Publications Teams

150        Figure 2.50: Performance Metrics Measured: Country-Level Publications Teams

151        Developing a Medical Publications Strategy: Establishing Timelines, Coordinating Activities and Targeting Key Journal Types

153        Figure 3.1: Companies’ Objectives for Medical Publications Strategy: All Teams

153        Publications Strategy Overview

154        Figure 3.2: Companies’ Objectives for Medical Publications Strategy: Companywide Teams

155        Figure 3.3: Companies’ Objectives for Medical Publications Strategy: Corporate-Level Business Unit Teams

156        Figure 3.4: Companies’ Objectives for Medical Publications Strategy: Country-Level Teams

161        Figure 3.5: Functions Involved in Medical Publications Strategy: All Companies

162         Figure 3.6: Functions Involved in Medical Publications Strategy: Companywide Teams

164         Figure 3.7: Functions Involved in Medical Publications Strategy: Corporate-Level Business Unit Teams

165        Figure 3.8: Functions Involved in Medical Publications Strategy: Country-Level Teams

167        Figure 3.9: Frequency at Which Medical Publications Teams and Involved Functions Meet

168        Figure 3.10: Frequency at Which Medical Publications Teams and Involved Functions Meet, by Team Type

173        Companies’ Publications Processes: Manuscript Development

175        Figure 3.11: Number of Manuscripts Produced and Published in 2012 by Large High-Output Teams with Companywide Responsibility

176        Figure 3.12: Number of Manuscripts Produced and Published in 2012 by Small High-Output Teams with Companywide Responsibility

177        Figure 3.13: Number of Manuscripts Produced and Published in 2012 by High-Output Teams Responsible for One Corporate Business Unit or One Country

178        Figure 3.14: Number of Manuscripts Produced and Published in 2012 by Low-Output Companywide Teams

179        Figure 3.15: Number of Manuscripts Produced and Published in 2012 by Low-Output Teams Responsible for One Corporate Business Unit

180        Figure 3.16: Number of Manuscripts Produced and Published in 2012 by Low-Output, Country-Level Teams

181        Figure 3.17: Number of Manuscripts Produced and Published in 2013 by Large High-Output Teams with Companywide Responsibility

183        Figure 3.18: Number of Manuscripts Produced and Published in 2013 by Small High-Output Teams with Companywide Responsibility

184        Figure 3.19: Number of Manuscripts Produced and Published in 2013 by High-Output Teams Responsible for One Corporate Business Unit or One Country

185        Figure 3.20: Number of Manuscripts Produced and Published in 2013 by Low-Output Companywide Teams

186        Figure 3.21: Number of Manuscripts Produced and Published in 2013 by Low-Output Teams Responsible for One Corporate Business Unit

187        Figure 3.22: Number of Manuscripts Produced and Published in 2013 by Low-Output, Country-Level Teams

188         Figure 3.23: Projected Number of Manuscripts Produced and Published in 2014 by High-Output Teams with Companywide Responsibility

189        Figure 3.24: Projected Number of Manuscripts Produced and Published in 2014 by High-Output Teams Responsible for One Corporate Business Unit or One Country

190        Figure 3.25: Projected Number of Manuscripts Produced and Published in 2014 by Low-Output Companywide Teams

191        Figure 3.26: Projected Number of Manuscripts Produced and Published in 2014 by Low-Output Teams Responsible for One Corporate Business Unit

192        Figure 3.27: Projected Number of Manuscripts Produced and Published in 2014 by Low-Output, Country-Level Teams

193        Figure 3.28: Number of Abstracts Developed per Year by Large High-Output Teams with Companywide Responsibility

193        Companies’ Publications Processes: Abstract Development

195        Figure 3.29: Number of Abstracts Developed per Year by High-Output Teams Responsible for One Corporate Business Unit or One Country

196        Figure 3.30: Number of Abstracts Developed per Year by Small High-Output Teams with Companywide Responsibility

197        Figure 3.31: Number of Abstracts Developed per Year by Low-Output Companywide Teams

198        Figure 3.32: Number of Abstracts Developed per Year by Low-Output Teams Responsible for One Corporate Business Unit

199        Figure 3.33: Number of Abstracts Developed per Year by Low-Output Country-Level Teams

200        Figure 3.34: Percentage of Abstracts Developed by High-Output Teams with Companywide Responsibility, by FTE Type

201        Figure 3.35: Percentage of Abstracts Developed by High-Output Teams Responsible for One Corporate Business Unit or One Country, by FTE Type

202        Figure 3.36: Percentage of Abstracts Developed by Low-Output Teams with Companywide Responsibility, by FTE Type

203        Figure 3.37: Percentage of Abstracts Developed by Low-Output Teams Responsible for One Corporate Business Unit, by FTE Type

203        Figure 3.38: Percentage of Abstracts Developed by Low-Output Country-Level Teams, by FTE Type

204        Choosing and Submitting to the Best-Fit Journal

208        Figure 3.39: Perceived Importance of Factors in Selecting a Journal: All Companies

209        Figure 3.40: Perceived Importance of Factors in Selecting a Journal: Companywide Teams

210        Figure 3.41: Perceived Importance of Factors in Selecting a Journal: Corporate-Level Business Unit Teams

211        Figure 3.42: Perceived Importance of Factors in Selecting a Journal: Country-Level Teams

212        Figure 3.43: Journals in Which Publications Teams Publish Research: All Companies

213        Figure 3.44: Other Publications in Which Publications Teams Publish Research: All Companies

214        Figure 3.45: Journals in Which Companies Publish Research: Companywide Publications Teams

215        Figure 3.46: Journals in Which Companies Publish Research: Corporate-Level Business Unit Publications Teams

215        Figure 3.47: Journals in Which Companies Publish Research: Country-Level Publications Teams

216        Figure 3.48: Other Publications in Which Companies Publish Research: Companywide Publications Teams

216         Figure 3.49: Other Publications in Which Companies Publish Research: Corporate-Level Business Unit Publications Teams

217        Figure 3.50: Other Publications in Which Companies Publish Research: Country-Level Publications Teams

218         Figure 3.51: Number of Contributions to Specific Journal Types in 2013: High Output Companywide Teams

219         Figure 3.52: Number of Contributions to Specific Journal Types in 2013: Low Output Companywide Teams

219         Figure 3.53: Number of Contributions to Specific Journal Types in 2013: Corporate-Level Business Unit Teams

220         Figure 3.54: Number of Contributions to Specific Journal Types in 2013: Country-Level Teams

221        Figure 3.55: Number of Contributions to Other Publication Types in 2013: High- Output Companywide Teams

222        Figure 3.56: Number of Contributions to Other Publication Types in 2013: Low-Output Companywide Teams

224        Figure 3.57: Number of Contributions to Other Publication Types in 2013: Corporate-Level Business Unit Teams

224        Figure 3.58: Number of Contributions to Other Publication Types in 2013: Country-Level Teams

225        Existing Challenges and Overall Perceptions of Current Publications Processes

226        Figure 3.59: Ratings of Challenges for Medical Publications Teams: All Companies

227        Figure 3.60: Ratings of Challenges for Medical Publications Teams with Companywide Responsibility

228         Figure 3.61: Ratings of Challenges for Medical Publications Teams Responsible for One Corporate Business Unit

228        Figure 3.62: Ratings of Challenges for Medical Publications Teams with Country-Level Responsibility

229        Figure 3.63: Companies’ Self-Assessment Ratings of Their Publications Efforts: Companywide Teams

230        Figure 3.64: Companies’ Self-Assessment Ratings of Their Publications Efforts: Corporate-Level Business Unit Teams

231        Figure 3.65: Companies’ Self-Assessment Ratings of Their Publications Efforts: Country-Level Teams

233        Benefits and Challenges of Increasing Transparency Across Publications

236         Advantages to the Public and Industry Driving Increased Transparency

242        Adhere Strictly to Multiple Sets of Guidelines for Optimal Transparency

243        Figure 4.1: Percentage of Companies that Follow ICMJE Guidelines

244        Figure 4.2: Percentage of Companies that Follow ICMJE Guidelines, by Group Type

245        Figure 4.3: Impact Ratings of 2013 Changes to ICMJE Guidelines

250        Figure 4.4: Percentage of Companies with an SOP in Place Requiring Publication of All Trials

250        Figure 4.5: Percentage of Companies with an SOP in Place Requiring Publication of All Trials, by Group Type

251        Figure 4.6: Percentage of Companies with a CIA that Affects Publications Activities

252        Figure 4.7: Percentage of Companies with a CIA that Affects Publications Activities, by Group Type

253        Figure 4.8: Ratings Showing CIAs’ Impact on Publications Activities at Companywide Groups

254        Figure 4.9: Ratings Showing CIAs’ Impact on Publications Activities at Corporate Business Unit Groups

254        Figure 4.10: Ratings Showing CIAs’ Impact on Publications Activities at Country-Level Groups

255        Figure 4.11: Number of Months Required to Implement Publications CIA

257         Figure 4.12: Percentage of Companies Requiring Additional Staffing to Support CIA

257         Figure 4.13: Percentage of Companies Requiring Additional Staffing to Support CIA, by Publications Group Type

258        Figure 4.14: Number of FTEs Added to Support CIA

259        Medical Publications Team Profiles

262        Figure 5.1: Company 1: Background and Publications Planning Timeline

263        Figure 5.2: Company 1: Journal Selection and Submission

264        Figure 5.3: Company 9: Background and Publications Planning Timeline

265        Figure 5.4: Company 9: Journal Selection and Submission

266        Figure 5.5: Company 21: Background and Publications Planning Timeline

267        Figure 5.6: Company 21: Journal Selection and Submission

268        Figure 5.7: Company 35: Background and Publications Planning Timeline

269        Figure 5.8: Company 35: Journal Selection and Submission

270        Figure 5.9: Company 5: Background and Publications Planning Timeline

271        Figure 5.10: Company 5: Journal Selection and Submission

272        Figure 5.11: Company 26: Background and Publications Planning Timeline

273         Figure 5.12: Company 26: Journal Selection and Submission

274        Figure 5.13: Company 27: Background and Publications Planning Timeline

275        Figure 5.14: Company 27: Journal Selection and Submission

276        Figure 5.15: Company 29: Background and Publications Planning Timeline

277        Figure 5.16: Company 29: Journal Selection and Submission

278        Figure 5.17: Company 35: Background and Publications Planning Timeline

279        Figure 5.18: Company 35: Journal Selection and Submission

280        Figure 5.19: Company 41: Background and Publications Planning Timeline

281        Figure 5.20: Company 41: Journal Selection and Submission

282        Figure 5.21: Company 42: Background and Publications Planning Timeline

283        Figure 5.22: Company 42: Journal Selection and Submission

284        Figure 5.23: Company 43: Background and Publications Planning Timeline

285        Figure 5.24: Company 43: Journal Selection and Submission